Latest News
Global Times: Three 'surprises' I got in the US while discussing the return of Chinese cultural artifacts - Huo Zhengxin
BEIJING, April 9, 2024 /PRNewswire/ -- In early April, the 118th Annual Meeting of the American Society of International Law (ASIL), the largest and most prestigious academic conference in the global international law community, took place inWashington DC as scheduled. Given the US' prominent rol...
AIMobile Debuts an Innovative Edge AI Box powered by Qualcomm
NUREMBERG, Germany, April 9, 2024 /PRNewswire/ -- AIMobile launches its latest Edge AI product today; AIM-Edge QC01 was designed with the aim to democratize Edge AI technologies and empower a wider range of applications with accessible entry-level computing power. Powered by the Qualcomm® QCS6490...
Momcozy Teams Up with Babylist to Celebrate Motherhood
NEW YORK, April 9, 2024 /PRNewswire/ -- In celebration of Mother's Day this
year, Momcozy
Yunnan: Doing businesses with Southeast Asia and beyond
KUNMING, China, April 8, 2024 /PRNewswire/ -- A news report from chinadaily.com.cn: Yunnan: Doing businesses with Southeast Asia and beyond Nestled in Southwest China, Yunnan province is emerging as a pivotal gateway to Southeast Asia and South Asia, bordered by Myanmar, Laos, and Vietnam. It...
Yunnan's Splendor: The Power of Imagination
KUNMING, China, April 8, 2024 /PRNewswire/ -- A news report from chinadaily.com.cn: Yunnan's Splendor: The Power of Imagination. The diverse landscape of Yunnan province presents its residents with a wealth of natural resources alongside numerous challenges. Drawing upon their ingenuity and p...
Abbisko Completed All Patient Enrollment for The Global Phase III TGCT Trial of Its CSF-1R Inhibitor - Pimicotinib
SHANGHAI, April 8, 2024 /PRNewswire/ -- 9 April 2024 (Beijing Time), Abbisko Therapeutics Co., Ltd. (Abbisko Therapeutics) announced the completion of patient enrollment for its pivotal Phase III trial, MANEUVER (ABSK021-301) STUDY, for evaluating the efficacy and safety of pimicotinib in patient...
Oral report | The positive interim analysis results from the Phase III clinical study of Akeso's Cadonilimab (PD-1/CTLA-4 BsAb) plus chemotherapy as first-line treatment for advanced gastric cancer presented at 2024 AACR
SAN DIEGO, April 8, 2024 /PRNewswire/ -- Akeso, Inc. (9926.HK) today announced thatthe positive interim analysis results from Phase III clinical study of Cadonilimab (PD-1/CTLA-4 BsAb)combined with XELOX (capecitabine plus oxaliplatin) as first-line treatment for unresectable locally advanced or ...
Nano Labs Files Annual Report on Form 20-F for Fiscal Year 2023
HANGZHOU, China, April 8, 2024 /PRNewswire/ -- Nano Labs Ltd (Nasdaq: NA) ("we," the "Company" or "Nano Labs"), a leading fabless integrated circuit design company and product solution provider inChina, announced today that it filed its annual report on Form 20-F for the fiscal year endedDecember...
Anycubic Unveils 2024 Strategy to Refine 3D Printing Experience
SHENZHEN, China, April 8, 2024 /PRNewswire/ -- On April 8, 2024, Anycubic
STRADVISION Enhances Automated Driving Solution with Next-Gen SVNet on Horizon Robotics Journey™ 3
SEOUL, South Korea, April 8, 2024 /PRNewswire/ -- Expanding on their strategic
partnership in mid-2023,STRADVISION
Anviz Unveils Innovative All-in-One Intelligent Security Solution for SMBs at ISC West 2024
Anviz One sets new industry leading standard for SMB security solutions
LAS VEGAS, April 8, 2024 /PRNewswire/ -- Poised to reaffirm its position as
an innovator in converged intelligent security systems,Anviz
U-tec to Show Smart Home Ecosystem U home at ISC West
U home mobile platform creates central command center that provides homeowners
with powerful tool to enhance security and automation
LAS VEGAS, April 8, 2024 /PRNewswire/ -- U-tec
SwitchBot Announces Major Upgrade for Matter Support
TOKYO, April 8, 2024 /PRNewswire/ -- SwitchBot, a leading smart home retrofitting and automation brand, officially announces its major upgrade for Matter. With this upgrade, almost all SwitchBot products, including the entire robotic vacuum collection, can now support Matter via SwitchBot Hub 2. ...
Ace Global Business Acquisition Limited Announces Extension of Combination Period and Additional Contribution to Trust Account to Extend Combination Period
NEW YORK, April 8, 2024 /PRNewswire/ -- Ace Global Business Acquisition Limited (NASDAQ: ACBA) (the "Company"), a special purpose acquisition company, announced today that at its annual general meeting of shareholders onApril 2, 2024, the Company's shareholders voted in favor of the proposal to a...
MAIWEIJIAN, First Approved Biosimilar of Denosumab (120mg) in China
SHANGHAI, April 8, 2024 /PRNewswire/ -- Mabwell (688062.SH), an innovation-driven biopharmaceutical company with entire industry chain, announced that Denosumab Injection (trade name: MAIWEIJIAN, R&D code: 9MW0321) developed by its wholly-owned subsidiary T-mab has officially obtained the market...
Medit Unveils i900: The Next Evolution of Intraoral Scanners
Secure a front-row seat for the debut of Medit i900 and discover the latest
cutting-edge dental technology
SEOUL, South Korea and LONG BEACH, Calif., April 8, 2024 /PRNewswire/ --
Medit (www.medit.com
Lunit's AI Demonstrates Up to 70% Workload Reduction and Enhanced Accuracy in Breast Cancer Screening: Study in European Radiology Reveals
- Employing Lunit INSIGHT MMG, a Turkish study showcases 70% efficiency improvements, advancements in early cancer detection, and interval cancer detection in mammography SEOUL, South Korea, April 8, 2024 /PRNewswire/ -- Lunit (KRX:328130.KQ), a leading provider of AI-powered solutions for cance...
ENGWE Marks a Decade of Innovation and Adventure with Special Anniversary Promotions
WASHINGTON, April 8, 2024 /PRNewswire/ -- As ENGWE proudly celebrates its 10th
anniversary
SeekIn Presents New OncoSeek® Data at the AACR Annual Meeting in San Diego
Two Sample Types, Three Different Platforms, Six Independent Cohorts of ~12,000 Cancer Patients and Non-cancer Individuals with Diverse Ethnic Backgrounds in Retrospective and Prospective Settings Validate OncoSeek's Ability to Detect Multiple Cancer Types and Predict the Tissue of Origin of Ca...
Aquaron Acquisition Corp. Announces Additional Contribution to Trust Account to Extend Period to Consummate Business Combination
NEW YORK, April 8, 2024 /PRNewswire/ -- Aquaron Acquisition Corp. (NASDAQ: AQU, the "Company"), a special purpose acquisition company, announced today that Bestpath IoT Technology Ltd. ("Bestpath") has deposited into the Company's trust account (the "Trust Account") an aggregate of $70,000, in or...
Week's Top Stories
Most Reposted
vVardis Raises $175 Million Ahead of NYSE IPO: NYSE Content Update
[Picked up by 1187 media titles]
2026-11-13 22:11The NYSE Welcomes vVARDIS as a Publicly Listed Company
[Picked up by 1173 media titles]
2026-11-14 13:23Cision Introduces AI-Powered Cision Intelligence to Help Brands See More and Act with Confidence
[Picked up by 1172 media titles]
2026-11-12 23:00Cyient, 3-GIS Partner to Help Telecom and Utility Operators Turn Network Data into Operational Control
[Picked up by 1155 media titles]
2026-11-11 22:00Kraft Heinz Casts Spotlight on its NYSE Listing: NYSE Content Update
[Picked up by 1088 media titles]
2026-11-12 21:55